Aehr Test Systems (AEHR) Competitors $18.86 -1.30 (-6.45%) Closing price 08/14/2025 04:00 PM EasternExtended Trading$18.93 +0.07 (+0.40%) As of 06:22 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AEHR vs. TXG, TRNS, EYPT, ALNT, LAB, CTKB, SENS, QTRX, FEIM, and QSIShould you be buying Aehr Test Systems stock or one of its competitors? The main competitors of Aehr Test Systems include 10x Genomics (TXG), Transcat (TRNS), EYEPOINT PHARMACEUTICALS (EYPT), Allient (ALNT), Standard BioTools (LAB), Cytek Biosciences (CTKB), Senseonics (SENS), Quanterix (QTRX), Frequency Electronics (FEIM), and Quantum-Si (QSI). These companies are all part of the "measuring and control equipment" industry. Aehr Test Systems vs. Its Competitors 10x Genomics Transcat EYEPOINT PHARMACEUTICALS Allient Standard BioTools Cytek Biosciences Senseonics Quanterix Frequency Electronics Quantum-Si Aehr Test Systems (NASDAQ:AEHR) and 10x Genomics (NASDAQ:TXG) are both small-cap measuring and control equipment companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, earnings, valuation, institutional ownership, media sentiment and risk. Which has more risk & volatility, AEHR or TXG? Aehr Test Systems has a beta of 2.35, indicating that its stock price is 135% more volatile than the S&P 500. Comparatively, 10x Genomics has a beta of 2.03, indicating that its stock price is 103% more volatile than the S&P 500. Does the media refer more to AEHR or TXG? In the previous week, 10x Genomics had 26 more articles in the media than Aehr Test Systems. MarketBeat recorded 30 mentions for 10x Genomics and 4 mentions for Aehr Test Systems. Aehr Test Systems' average media sentiment score of 0.95 beat 10x Genomics' score of 0.55 indicating that Aehr Test Systems is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aehr Test Systems 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive 10x Genomics 6 Very Positive mention(s) 6 Positive mention(s) 10 Neutral mention(s) 4 Negative mention(s) 0 Very Negative mention(s) Positive Is AEHR or TXG more profitable? Aehr Test Systems has a net margin of -6.63% compared to 10x Genomics' net margin of -13.13%. Aehr Test Systems' return on equity of -0.15% beat 10x Genomics' return on equity.Company Net Margins Return on Equity Return on Assets Aehr Test Systems-6.63% -0.15% -0.13% 10x Genomics -13.13%-12.88%-10.03% Do institutionals and insiders have more ownership in AEHR or TXG? 69.7% of Aehr Test Systems shares are owned by institutional investors. Comparatively, 84.7% of 10x Genomics shares are owned by institutional investors. 6.2% of Aehr Test Systems shares are owned by company insiders. Comparatively, 9.4% of 10x Genomics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Do analysts rate AEHR or TXG? 10x Genomics has a consensus price target of $13.54, indicating a potential upside of 2.28%. Given 10x Genomics' stronger consensus rating and higher probable upside, analysts clearly believe 10x Genomics is more favorable than Aehr Test Systems.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aehr Test Systems 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.0010x Genomics 1 Sell rating(s) 6 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.38 Which has better valuation and earnings, AEHR or TXG? Aehr Test Systems has higher earnings, but lower revenue than 10x Genomics. Aehr Test Systems is trading at a lower price-to-earnings ratio than 10x Genomics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAehr Test Systems$58.97M9.57-$3.91M-$0.13-145.0810x Genomics$610.78M2.67-$182.63M-$0.70-18.91 SummaryAehr Test Systems and 10x Genomics tied by winning 8 of the 16 factors compared between the two stocks. Get Aehr Test Systems News Delivered to You Automatically Sign up to receive the latest news and ratings for AEHR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AEHR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AEHR vs. The Competition Export to ExcelMetricAehr Test SystemsELEC MSRNG INST IndustryComputer SectorNASDAQ ExchangeMarket Cap$603.09M$6.83B$30.04B$9.84BDividend YieldN/A0.26%3.08%4.07%P/E Ratio-145.0726.6552.2625.74Price / Sales9.575.361,294.15115.79Price / Cash187.5059.3636.4959.48Price / Book4.576.199.116.15Net Income-$3.91M$297.53M$803.97M$265.06M7 Day Performance3.63%3.66%1.18%2.60%1 Month Performance34.23%12.73%0.85%2.83%1 Year Performance27.95%29.67%24,075.66%25.58% Aehr Test Systems Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AEHRAehr Test Systems2.2603 of 5 stars$18.86-6.4%N/A+39.1%$603.09M$58.97M-145.0790Positive NewsGap UpTXG10x Genomics3.7609 of 5 stars$13.68+4.6%$13.23-3.3%-33.0%$1.68B$624.66M-10.521,240Trending NewsAnalyst ForecastTRNSTranscat3.5522 of 5 stars$74.80+0.3%$112.20+50.0%-30.7%$697.14M$278.42M47.951,245News CoveragePositive NewsAnalyst RevisionEYPTEYEPOINT PHARMACEUTICALS1.6944 of 5 stars$10.06+3.6%$25.67+155.1%+43.1%$692.23M$43.27M-4.17120ALNTAllient2.9159 of 5 stars$39.67+4.3%$31.00-21.9%+111.5%$671.61M$529.97M67.242,525LABStandard BioTools3.03 of 5 stars$1.32+1.5%$2.50+89.4%-21.3%$493.77M$169.69M-3.77620Analyst DowngradeGap DownCTKBCytek Biosciences3.2922 of 5 stars$3.84+5.5%$5.60+45.8%-23.0%$461.04M$197.05M-42.66500Gap DownSENSSenseonics2.317 of 5 stars$0.51+3.9%$1.55+205.2%+22.3%$332.21M$23.68M-3.9190QTRXQuanterix2.1521 of 5 stars$6.04+3.1%$13.50+123.5%-59.5%$301.70M$137.42M-4.65460FEIMFrequency Electronics1.5168 of 5 stars$27.73+4.8%N/A+157.7%$269.81M$69.81M11.23200Gap DownHigh Trading VolumeQSIQuantum-Si3.0606 of 5 stars$1.44-1.4%$3.48+141.3%+27.2%$267.91M$3.44M-2.12150 Related Companies and Tools Related Companies TXG Competitors TRNS Competitors EYPT Competitors ALNT Competitors LAB Competitors CTKB Competitors SENS Competitors QTRX Competitors FEIM Competitors QSI Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AEHR) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aehr Test Systems Please log in to your account or sign up in order to add this asset to your watchlist. Share Aehr Test Systems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access